Rituximab

Active ingredient
Rituximab
Pharma Company
Roche Pharma AG/ Roche Deutschland Holding GmbH
Total Number of Doctors1
141 doctors
Total Number of Patients2
721 patients
Total minimum fees planned3
413,000.00 €

Observational Studies including Rituximab

Drug No. of doctors1 No. of patients2 Payment per patient3
Rituximab (MabThera) 135 700 575.00 € pro ordnungsgemäß ausgefülltem Dokumentationsbogen, bei Ablieferung der vereinbarten maximalen 5 Dokumentationsbögen =2.500 €
Rituximab 6 21 500.00 € über 5 Jahre, 100€/h zugrundegelegt

Background

Independent journalism needs independent funding

Others can write stories. We want to reveal. We are the first investigative newsroom in Germany, which is independent, ad-free, and non-profit.

For us, the core of journalism means uncovering injustice and shortcomings in society. That’s why we investigate corruption in the health system, politicians abusing their power, and an elite that believes that rules are for the others.

To do our job, we need people, who support us. We ask you, too, to become a member and enable the work of 16 investigative journalists at CORRECTIV.

We are convinced that without independent and critical media, democracy fought for and won by our ancestors, cannot survive for long.